Losartan benefits over atenolol in non‐smoking hypertensive patients with left ventricular hypertrophy: The LIFE study-Reference-Cited by-同舟云学术

Losartan benefits over atenolol in non‐smoking hypertensive patients with left ventricular hypertrophy: The LIFE study

Published:2004-01 Issue:6 Volume:13 Page:376-384
ISSN:0803-7051
Container-title:Blood Pressure
language:en
Short-container-title:Blood Pressure

Author:

Reims Henrik,Oparil Suzanne,KJELDSEN Sverre,Devereux Richard,Julius Stevo,Brady William,Fyhrquist Frej,Ibsen Hans,Lindholm Lars,Omvik Per,Wedel Hans,Beevers Gareth,De Faire Ulf,Kristianson Krister,Lederballe‐Pedersen Ole,Nieminen Markku,Dahlöf Björn,

Publisher

Informa UK Limited

Subject

Cardiology and Cardiovascular Medicine,General Medicine,Internal Medicine

Link

http://www.tandfonline.com/doi/pdf/10.1080/08037050410016483

Reference33 articles.

1. Meta-analysis of relation between cigarette smoking and stroke.

2. Primary Prevention of Ischemic Stroke

Cited by 14 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Physical fitness is a modifiable predictor of early cardiovascular death: A 35-year follow-up study of 2014 healthy middle-aged men;European Journal of Preventive Cardiology;2018-08-14

2. Fifteen years of LIFE (Losartan Intervention for Endpoint Reduction in Hypertension)-Lessons learned for losartan: An “old dog playing good tricks”;The Journal of Clinical Hypertension;2018-06-15

3. Correlation between Serum Calcineurin Activity and Left Ventricular Hypertrophy in Hypertensive Patients and Its Clinical Significance;Cardiology;2018

4. Hypertension and stroke: an appraisal of the evidence and implications for clinical management;Expert Review of Cardiovascular Therapy;2016-02-12

5. Factors Influencing the Decline in Stroke Mortality;Stroke;2014-01